Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.

Dehlendorff C, Sparén P, Baldur-Felskov B, Herweijer E, Arnheim-Dahlström L, Ploner A, Uhnoo I, Kjaer SK.

Vaccine. 2018 Oct 15;36(43):6373-6378. doi: 10.1016/j.vaccine.2018.09.011. Epub 2018 Sep 21.

PMID:
30249423
2.

Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline data.

Vänskä S, Söderlund-Strand A, Uhnoo I, Lehtinen M, Dillner J.

Vaccine. 2018 May 31;36(23):3239-3246. doi: 10.1016/j.vaccine.2018.04.073. Epub 2018 Apr 30.

PMID:
29716776
3.

[Polio close to eradication].

Norrby E, Uhnoo I, Brytting M, Zakikhany K, Lepp T, Olin P.

Lakartidningen. 2017 Sep 19;114. pii: EPDT. Review. Swedish.

4.

Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.

Lamb F, Herweijer E, Ploner A, Uhnoo I, Sundström K, Sparén P, Arnheim-Dahlström L.

BMJ Open. 2017 Jun 8;7(6):e015021. doi: 10.1136/bmjopen-2016-015021.

5.

Highest Vaccine Uptake after School-Based Delivery - A County-Level Evaluation of the Implementation Strategies for HPV Catch-Up Vaccination in Sweden.

Rehn M, Uhnoo I, Kühlmann-Berenzon S, Wallensten A, Sparén P, Netterlid E.

PLoS One. 2016 Mar 14;11(3):e0149857. doi: 10.1371/journal.pone.0149857. eCollection 2016.

6.

Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.

Herweijer E, Sundström K, Ploner A, Uhnoo I, Sparén P, Arnheim-Dahlström L.

Int J Cancer. 2016 Jun 15;138(12):2867-74. doi: 10.1002/ijc.30035. Epub 2016 Mar 9. Erratum in: Int J Cancer. 2017 Jul 1;141(1):E1-E4.

7.

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.

Herweijer E, Feldman AL, Ploner A, Arnheim-Dahlström L, Uhnoo I, Netterlid E, Dillner J, Sparén P, Sundström K.

PLoS One. 2015 Jul 28;10(7):e0134185. doi: 10.1371/journal.pone.0134185. eCollection 2015.

8.

Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.

Hedenstierna M, Weiland O, Brass A, Bankwitz D, Behrendt P, Uhnoo I, Aleman S, Cardell K, Fryden A, Norkrans G, Eilard A, Glaumann H, Pietschmann T, Sällberg M, Brenndörfer ED.

Aliment Pharmacol Ther. 2015 Mar;41(6):532-43. doi: 10.1111/apt.13096. Epub 2015 Jan 28.

9.

Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study.

Söderlund-Strand A, Uhnoo I, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2757-64. doi: 10.1158/1055-9965.EPI-14-0687. Epub 2014 Nov 7.

10.

[Whooping cough is a risk to infants. The disease is circulating among adolescents and adults].

Nilsson L, Von Segebaden K, Blennow M, Linde A, Uhnoo I.

Lakartidningen. 2013 Sep 11-17;110(37):1599-602. Review. Swedish. No abstract available.

PMID:
24163932
11.

Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden.

Widgren K, Magnusson M, Hagstam P, Widerström M, Örtqvist Å, Einemo IM, Follin P, Lindblom A, Mäkitalo S, Wik O, Österlund A, Grünewald M, Uhnoo I, Linde A.

Euro Surveill. 2013 Apr 11;18(15):20447.

12.

[Life-threatening infection in splenectomised patients is preventable. But this requires better vaccination routines, education and antibiotic prophylaxis].

Uhnoo I, Lepp T.

Lakartidningen. 2012 Aug 8-21;109(32-33):1406-10. Review. Swedish. No abstract available.

PMID:
22953428
13.

Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations.

Lagging M, Wejstål R, Uhnoo I, Gerdén B, Fischler B, Friman S, Josephson F, Karlström O, Sangfelt P, Schvarz R, Weiland O; Swedish Consensus Group.

Scand J Infect Dis. 2009;41(6-7):389-402. doi: 10.1080/00365540902998271. Review.

PMID:
20001276
14.

[New guidelines for more efficient treatment of hepatitis C. Individualized therapy increases the chance of cure].

Wejstål R, Uhnoo I.

Lakartidningen. 2009 Sep 23-29;106(39):2438. Swedish. No abstract available.

PMID:
19852161
15.

[The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].

Uhnoo I, Bergquist C.

Lakartidningen. 2009 Jul 8-21;106(28-29):1814-9. Review. Swedish. No abstract available.

PMID:
19685621
16.

Treatment of chronic hepatitis B infection: an update of Swedish recommendations.

Lindh M, Uhnoo I, Bläckberg J, Duberg AS, Friman S, Fischler B, Karlström O, Norkrans G, Reichard O, Sangfeldt P, Söderström A, Sönnerborg A, Weiland O, Wejstål R, Wiström J.

Scand J Infect Dis. 2008;40(6-7):436-50. doi: 10.1080/00365540802154769. Review.

PMID:
18584530
17.
18.

Antiretroviral treatment of HIV infection: Swedish recommendations 2005.

Gisslén M, Ahlqvist-Rastad J, Albert J, Blaxhult A, Hamberg AK, Lindbäck S, Sandström E, Uhnoo I; Swedish Consensus Group.

Scand J Infect Dis. 2006;38(2):86-103.

PMID:
16562361
19.

[Oseltamivir resistant avian influenza unsettling. Private hoarding of influenza agents a potential threat against public health].

Uhnoo I, Linde A.

Lakartidningen. 2006 Feb 1-7;103(5):298-300. Swedish. No abstract available.

PMID:
16512569
20.

[Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].

Uhnoo I, Linde A.

Lakartidningen. 2005 Dec 5-11;102(49):3802-3, 3805-6, 3808. Review. Swedish.

PMID:
16408704
21.

Serum ALT levels as a surrogate marker for serum HBV DNA levels in HBeAg-negative pregnant women.

Sangfelt P, Von Sydow M, Uhnoo I, Weiland O, Lindh G, Fischler B, Lindgren S, Reichard O.

Scand J Infect Dis. 2004;36(3):182-5.

PMID:
15119362
22.

Chronic hepatitis C: updated Swedish consensus.

Wejstål R, Alaeus A, Fischler B, Reichard O, Uhnoo I, Weiland O; Swedish National Expert Panel for the treatment of chronic hepatitis C.

Scand J Infect Dis. 2003;35(8):445-51. Review.

PMID:
14514142
23.

Antiretroviral treatment of human immunodeficiency virus infection: Swedish recommendations.

Sandström E, Uhnoo I, Ahlqvist-Rastad J, Bratt G, Berglund T, Gisslén M, Lindbäck S, Morfeldt L, Ståhle L, Sönnerborg A; Swedish Consensus Group.

Scand J Infect Dis. 2003;35(3):155-67. Review.

PMID:
12751710
24.

Treatment and prevention of influenza: Swedish recommendations.

Uhnoo I, Linde A, Pauksens K, Lindberg A, Eriksson M, Norrby R; Swedish Consensus Group.

Scand J Infect Dis. 2003;35(1):3-11. Review.

PMID:
12685876
25.
26.
27.

Chronic hepatitis C--Swedish experts' meeting recommends combination treatment.

Wejstål R, Fischler B, Glaumann H, Norkrans G, Reichard O, Sönnerbor A, Uhnoo I, Weiland O; Swedish Reference Group for Antiviral Therapy; Medical Products Agency.

Scand J Infect Dis. 2000;32(5):465-70. No abstract available.

PMID:
11055647
28.

Incidence and genetic diversity of group C rotavirus among adults.

Nilsson M, Svenungsson B, Hedlund KO, Uhnoo I, Lagergren A, Akre T, Svensson L.

J Infect Dis. 2000 Sep;182(3):678-84. Epub 2000 Aug 3.

PMID:
10950759
29.

Reply

Frey S, Dagan R, Ashur Y, Chen XQ, Ibarra J, Kollaritsch H, Mazur MH, Poland GA, Reisinger K, Walter E, Van Damme P, Braconier JH, Uhnoo I I, Wahl M, Blatter MM, Clements D, Greenberg D, Jacobson RM, Norrby SR, Rowe M, Shouval D, Simmons SS, van Hattum J, Wennerholm S, O'Brien Gress J, Chan I I.

J Infect Dis. 2000 Sep;182(3):1005-6. No abstract available.

PMID:
10950808
30.

Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea.

Lundgren O, Peregrin AT, Persson K, Kordasti S, Uhnoo I, Svensson L.

Science. 2000 Jan 21;287(5452):491-5.

31.

[Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin].

Wejstål R, Fischler B, Glaumann H, Norkrans G, Reichard O, Sönnerborg A, Uhnoo I, Weiland O.

Lakartidningen. 1999 Nov 3;96(44):4795-8, 4800. Swedish. No abstract available.

PMID:
10584541
32.

Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.

Frey S, Dagan R, Ashur Y, Chen XQ, Ibarra J, Kollaritsch H, Mazur MH, Poland GA, Reisinger K, Walter E, Van Damme P, Braconier JH, Uhnoo I, Wahl M, Blatter MM, Clements D, Greenberg D, Jacobson RM, Norrby SR, Rowe M, Shouval D, Simmons SS, van Hattum J, Wennerholm S, Gress JO, et al.

J Infect Dis. 1999 Dec;180(6):2018-22. Erratum in: J Infect Dis 2000 Feb;181(2):814.

PMID:
10558961
33.

Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis C.

Weiland O, Braconier JH, Frydén A, Norkrans G, Reichard O, Uhnoo I.

Scand J Infect Dis. 1999;31(2):115-8.

PMID:
10447316
34.

[The first rotavirus vaccine approved in the USA and Europe].

Svensson L, Johansen K, Uhnoo I.

Lakartidningen. 1999 Jun 30;96(26-27):3158-60. Review. Swedish.

PMID:
10423974
35.

Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres.

Sturesson C, Artursson P, Ghaderi R, Johansen K, Mirazimi A, Uhnoo I, Svensson L, Albertsson AC, Carlfors J.

J Control Release. 1999 Jun 2;59(3):377-89.

PMID:
10332067
36.

Incidence and estimates of the disease burden of rotavirus in Sweden.

Johansen K, Bennet R, Bondesson K, Eriksson M, Hedlund KO, De Verdier Klingenberg K, Uhnoo I, Svensson L.

Acta Paediatr Suppl. 1999 Jan;88(426):20-3.

PMID:
10088907
37.

Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region.

Norder H, Bergström A, Uhnoo I, Aldén J, Weiss L, Czajkowski J, Magnius L.

J Clin Microbiol. 1998 Oct;36(10):3066-9.

38.

Virological, biochemical and histological effects of human lymphoblastoid interferon in Swedish patients with chronic hepatitis C.

Garson JA, Uhnoo I, Whitby K, Braconier JH, Deaville R, Duberg A, Wallmark E, Wiström J, Goldin RD, Spacey B.

J Viral Hepat. 1997 Sep;4(5):325-31.

PMID:
9310931
39.

Characterization of a spotted fever group Rickettsia from Ixodes ricinus ticks in Sweden.

Nilsson K, Jaenson TG, Uhnoo I, Lindquist O, Pettersson B, Uhlén M, Friman G, Påhlson C.

J Clin Microbiol. 1997 Jan;35(1):243-7.

40.

Detection of group C rotavirus in infants with extrahepatic biliary atresia.

Riepenhoff-Talty M, Gouvea V, Evans MJ, Svensson L, Hoffenberg E, Sokol RJ, Uhnoo I, Greenberg SJ, Schäkel K, Zhaori G, Fitzgerald J, Chong S, el-Yousef M, Nemeth A, Brown M, Piccoli D, Hyams J, Ruffin D, Rossi T.

J Infect Dis. 1996 Jul;174(1):8-15.

PMID:
8656017
41.

Serum IgA immune response to individual rotavirus polypeptides in young children with rotavirus infection.

Johansen K, Granqvist L, Karlén K, Stintzing G, Uhnoo I, Svensson L.

Arch Virol. 1994;138(3-4):247-59.

PMID:
7998832
42.

Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice.

Riepenhoff-Talty M, Schaekel K, Clark HF, Mueller W, Uhnoo I, Rossi T, Fisher J, Ogra PL.

Pediatr Res. 1993 Apr;33(4 Pt 1):394-9.

PMID:
8386833
43.

First documented case of human babesiosis in Sweden.

Uhnoo I, Cars O, Christensson D, Nyström-Rosander C.

Scand J Infect Dis. 1992;24(4):541-7.

PMID:
1411322
44.

[Self administration of antibiotics in traveller's diarrhea. Advantages are not in balance with the risks].

Cars O, Uhnoo I, Linglöf T, Svenungsson B, Burman L.

Lakartidningen. 1990 Sep 5;87(36):2751-2. Swedish. No abstract available.

PMID:
2214989
45.

Enteric adenoviruses.

Uhnoo I, Svensson L, Wadell G.

Baillieres Clin Gastroenterol. 1990 Sep;4(3):627-42. Review.

PMID:
1962727
46.

Effect of rotavirus infection and malnutrition on uptake of a dietary antigen in the intestine.

Uhnoo IS, Freihorst J, Riepenhoff-Talty M, Fisher JE, Ogra PL.

Pediatr Res. 1990 Feb;27(2):153-60.

PMID:
2314944
47.

Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus.

Uhnoo I, Riepenhoff-Talty M, Dharakul T, Chegas P, Fisher JE, Greenberg HB, Ogra PL.

J Virol. 1990 Jan;64(1):361-8.

48.

Effect of nutritional deprivation on mucosal viral infections.

Riepenhoff-Talty M, Uhnoo I, Chegas P, Ogra PL.

Immunol Invest. 1989 Jan-May;18(1-4):127-39.

PMID:
2543624
49.

Immunological aspects of interaction between rotavirus and the intestine in infancy.

Uhnoo I, Dharakul T, Riepenhoff-Talty M, Ogra PL.

Immunol Cell Biol. 1988 Apr;66 ( Pt 2):135-45. Review.

PMID:
2846434
50.

Update of viral gastroenteritis.

Uhnoo I, Olding-Stenkvist E, Wadell G.

Dig Dis. 1988;6(2):102-16. Review. No abstract available.

PMID:
2834120

Supplemental Content

Support Center